Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Apr 23, 2022 11:23am
96 Views
Post# 34626174

RE:RE:RE:GUD and INFLATION

RE:RE:RE:GUD and INFLATION"You can't compare Palladin Capital base vs GUD. You can't do this. GUD made the mistake to raise too much cash + invest in funds."

----------------------------------------

That was no mistake ...

There are roughly 8x more shares.
That is understood and must be considered in any analysis
Our revenue is 10x that of Paladin's - after year 7

What I'm saying is - after 7 years we're in 11 countries and distribution in many other smaller markets.  We have 100% ownership of this ROW.  Paladin didn't even look outside Canada until year 10-11.  They didn't expand their ownership in Sub-saharan Africa until 2012 and still, they didn't have more than 44% ownership of African assets.

We are way ahead of the game - that's what I'm saying.

Yes - investment fund money will slowly convert to cash and cash will be used to acquire operational assets and to buyback shares.  Eventually the buybacks stop - same game as the first time, just faster paced and with experience.

The operations score card looks good right now (GUD vs. PLB) - and - we'll likely be in other European/Asian/African geographies by the time Paladin would have only been thinking about moving outside Canada.

The comparision is important - as Goodman's goal has always been to outshine PLB. 
<< Previous
Bullboard Posts
Next >>